Prior to joining the Cannabis Industry in 2017, I spent six years working as a consultant for international corporate companies with a focus on financial services. Over the past few years, I shifted my focus to working with some of Europe’s largest cannabis companies. During this time, my main responsibilities have included; expanding business development, establishing distribution centers throughout Europe and managing supply chains. My first employers’ in the Cannabis Space were a vertical integrated Swiss company who had high demand for their products, during my time with them I was heavily involved in producing raw materials such as isolates and distillates. This experience allowed me to gain a profound technical understanding of the production process, which in turn helped me to sell the products more effectively. During the last couple of years, the price of raw materials has dropped considerably, therefore in my opinion the most valuable asset a company in the Cannabis sector can have, is a loyal customer base as well as an established sales and manufacturing infrastructure in key locations such as Europe and Asia. As our management team were able to bring these key components together, we made the strategic decision to launch Astrasana Holdings in the summer of 2022. Our decision to hold a key focus on the international distribution of Medical Cannabis products has proven a successful one. Within a year of being formed we now have thirty employees spread across seven subsidiaries and we distribute our products in eighteen countries worldwide.